Review| Volume 69, ISSUE 3, P244-248, July 2011

Oesophageal adenocarcinoma: The new epidemic in men?

  • Martin Rutegård
    Corresponding author at: Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, N:a Stationsgatan 76, 2nd floor, SE-171 76 Stockholm, Sweden. Tel.: +46 8 517 709 83.
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Search for articles by this author
  • Pernilla Lagergren
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Search for articles by this author
  • Helena Nordenstedt
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Search for articles by this author
  • Jesper Lagergren
    Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    Division of Cancer Studies, King's College, London, United Kingdom
    Search for articles by this author


      The last decades have witnessed an unprecedented rise in the incidence of oesophageal adenocarcinoma. This rise has mainly affected men, and current male-to-female sex ratio estimates range from 7–10 to 1. Major risk factors for oesophageal adenocarcinoma are gastro-oesophageal reflux disease and obesity, especially in combination. The prevalence of these risk factors has increased during the last decades, but there does not seem to be a marked differential distribution among men and women. However, reflux among men is more often associated with erosive reflux disease than it is among women. There is also evidence that male-type obesity, with a prominent abdominal distribution of fat, confers a greater risk increase for oesophageal adenocarcinoma than the female equivalent. Due to the marked male predominance and the finding that women tend to develop specialized intestinal metaplasia (Barrett's oesophagus) and adenocarcinoma at a later age than men, interest has been directed towards a potential aetiological role of reproductive factors and sex hormones. Breastfeeding has been found to be a protective factor for the development of adenocarcinoma, while no association has hitherto been established with other reproductive factors. Taken together, the male predominance in the incidence of oesophageal adenocarcinoma may partly be explained by the differential effect of the major risk factors reflux disease and obesity, but the mechanisms whereby this occurs need to be elucidated. Moreover, the association with breastfeeding indicates a need for extensive epidemiological studies to clarify a possible role of sex hormonal influence in the aetiology of oesophageal adenocarcinoma.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jemal A.
        • Bray F.
        • Center M.M.
        • Ferlay J.
        • Ward E.
        • Forman D.
        Global cancer statistics.
        CA Cancer J Clin. 2011; 61: 134
        • Devesa S.S.
        • Blot W.J.
        • Fraumeni Jr., J.F.
        Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.
        Cancer. 1998; 83: 2049-2053
        • Brown L.M.
        • Devesa S.S.
        • Chow W.H.
        Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.
        J Natl Cancer Inst. 2008; 100: 1184-1187
      1. Lagergren J, Mattsson F. No further increase in the incidence of esophageal adenocarcinoma in Sweden. Int J Cancer; 2010 September 28 [Epub ahead of print].

        • Pohl H.
        • Sirovich B.
        • Welch H.G.
        Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010; 19: 1468-1470
        • Vizcaino A.P.
        • Moreno V.
        • Lambert R.
        • Parkin D.M.
        Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995.
        Int J Cancer. 2002; 99: 860-868
        • Chandanos E.
        • Lagergren J.
        The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen.
        Eur J Cancer. 2009; 45: 3149-3155
        • Lagergren J.
        • Bergstrom R.
        • Lindgren A.
        • Nyren O.
        Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
        N Engl J Med. 1999; 340: 825-831
        • Lagergren J.
        • Bergstrom R.
        • Nyren O.
        Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
        Ann Intern Med. 1999; 130: 883-890
        • Whiteman D.C.
        • Sadeghi S.
        • Pandeya N.
        • et al.
        Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.
        Gut. 2008; 57: 173-180
        • Lagergren J.
        • Ye W.
        • Bergstrom R.
        • Nyren O.
        Utility of endoscopic screening for upper gastrointestinal adenocarcinoma.
        JAMA. 2000; 284: 961-962
        • Ogden C.L.
        • Yanovski S.Z.
        • Carroll M.D.
        • Flegal K.M.
        The epidemiology of obesity.
        Gastroenterology. 2007; 132: 2087-2102
        • El-Serag H.B.
        Time trends of gastroesophageal reflux disease: a systematic review.
        Clin Gastroenterol Hepatol. 2007; 5: 17-26
        • Gammon M.D.
        • Schoenberg J.B.
        • Ahsan H.
        • et al.
        Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.
        J Natl Cancer Inst. 1997; 89: 1277-1284
        • Lindblad M.
        • Rodriguez L.A.
        • Lagergren J.
        Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case–control study.
        Cancer Causes Control. 2005; 16: 285-294
        • Gonzalez C.A.
        • Pera G.
        • Agudo A.
        • et al.
        Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
        Int J Cancer. 2006; 118: 2559-2566
        • Jansson C.
        • Johansson A.L.
        • Nyren O.
        • Lagergren J.
        Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case–control study.
        Cancer Epidemiol Biomarkers Prev. 2005; 14: 1754-1761
        • Sadeghi S.
        • Bain C.J.
        • Pandeya N.
        • Webb P.M.
        • Green A.C.
        • Whiteman D.C.
        Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
        Cancer Epidemiol Biomarkers Prev. 2008; 17: 1169-1178
        • Lagergren J.
        • Ye W.
        • Lindgren A.
        • Nyren O.
        Heredity and risk of cancer of the esophagus and gastric cardia.
        Cancer Epidemiol Biomarkers Prev. 2000; 9: 757-760
        • Ji J.
        • Hemminki K.
        Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
        Clin Gastroenterol Hepatol. 2006; 4: 840-845
        • Reid B.J.
        • Li X.
        • Galipeau P.C.
        • Vaughan T.L.
        Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
        Nat Rev Cancer. 2010; 10: 87-101
        • Cameron A.J.
        • Lomboy C.T.
        • Pera M.
        • Carpenter H.A.
        Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.
        Gastroenterology. 1995; 109: 1541-1546
        • Solaymani-Dodaran M.
        • Logan R.F.
        • West J.
        • Card T.
        • Coupland C.
        Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
        Gut. 2004; 53: 1070-1074
        • Cook M.B.
        • Wild C.P.
        • Forman D.
        A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease.
        Am J Epidemiol. 2005; 162: 1050-1061
        • Corley D.A.
        • Kubo A.
        • Levin T.R.
        • et al.
        Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994–2006.
        Gut. 2009; 58: 182-188
        • van Blankenstein M.
        • Looman C.W.
        • Johnston B.J.
        • Caygill C.P.
        Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center.
        Am J Gastroenterol. 2005; 100: 568-576
        • Locke 3rd G.R.
        • Talley N.J.
        • Fett S.L.
        • Zinsmeister A.R.
        • Melton 3rd. L.J.
        Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County Minnesota.
        Gastroenterology. 1997; 112: 1448-1456
        • Nilsson M.
        • Johnsen R.
        • Ye W.
        • Hveem K.
        • Lagergren J.
        Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex.
        Scand J Gastroenterol. 2004; 39: 1040-1045
        • Ogden C.L.
        • Carroll M.D.
        • Curtin L.R.
        • McDowell M.A.
        • Tabak C.J.
        • Flegal K.M.
        Prevalence of overweight and obesity in the United States, 1999–2004.
        JAMA. 2006; 295: 1549-1555
        • Andreyeva T.
        • Michaud P.C.
        • van Soest A.
        Obesity and health in Europeans aged 50 years and older.
        Public Health. 2007; 121: 497-509
        • Ali S.M.
        • Chaix B.
        • Merlo J.
        • Rosvall M.
        • Wamala S.
        • Lindstrom M.
        Gender differences in daily smoking prevalence in different age strata: a population-based study in southern Sweden.
        Scand J Public Health. 2009; 37: 146-152
        • Freedman N.D.
        • Derakhshan M.H.
        • Abnet C.C.
        • Schatzkin A.
        • Hollenbeck A.R.
        • McColl K.E.
        Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women.
        Eur J Cancer. 2010; 46: 2473-2478
        • Larsson S.C.
        • Giovannucci E.
        • Wolk A.
        Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden.
        Br J Cancer. 2006; 95: 1277-1279
        • de Martel C.
        • Parsonnet J.
        Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys.
        Dig Dis Sci. 2006; 51: 2292-2301
        • Rutegard M.
        • Nordenstedt H.
        • Lu Y.
        • Lagergren J.
        • Lagergren P.
        Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma.
        Br J Cancer. 2010; 103: 735-740
        • Vakil N.
        • van Zanten S.V.
        • Kahrilas P.
        • Dent J.
        • Jones R.
        The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.
        Am J Gastroenterol. 2006; 101 (quiz 1943): 1900-1920
        • Zagari R.M.
        • Fuccio L.
        • Wallander M.A.
        • et al.
        Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano–Monghidoro study.
        Gut. 2008; 57: 1354-1359
        • Peng S.
        • Cui Y.
        • Xiao Y.L.
        • et al.
        Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
        Endoscopy. 2009; 41: 1011-1017
        • Ryan A.M.
        • Rowley S.P.
        • Fitzgerald A.P.
        • Ravi N.
        • Reynolds J.V.
        Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.
        Eur J Cancer. 2006; 42: 1151-1158
        • Lofdahl H.E.
        • Lu Y.
        • Lagergren J.
        Sex-specific risk factor profile in oesophageal adenocarcinoma.
        Br J Cancer. 2008; 99: 1506-1510
        • Beddy P.
        • Howard J.
        • McMahon C.
        • et al.
        Association of visceral adiposity with oesophageal and junctional adenocarcinomas.
        Br J Surg. 2010; 97: 1028-1034
        • Corley D.A.
        • Kubo A.
        • Zhao W.
        Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.
        Cancer Epidemiol Biomarkers Prev. 2008; 17: 352-358
        • El-Serag H.
        Role of obesity in GORD-related disorders.
        Gut. 2008; 57: 281-284
        • Howard J.M.
        • Beddy P.
        • Ennis D.
        • Keogan M.
        • Pidgeon G.P.
        • Reynolds J.V.
        Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma.
        Br J Surg. 2010; 97: 1020-1027
        • Kendall B.J.
        • Macdonald G.A.
        • Hayward N.K.
        • et al.
        Leptin and the risk of Barrett's oesophagus.
        Gut. 2008; 57: 448-454
        • Thompson O.M.
        • Beresford S.A.
        • Kirk E.A.
        • Bronner M.P.
        • Vaughan T.L.
        Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
        Obesity (Silver Spring). 2010; 18: 2204-2211
        • Schouten L.J.
        • Kiemeney L.A.
        Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands.
        Eur J Cancer. 1997; 33: 1519
        • Cook M.B.
        • Dawsey S.M.
        • Freedman N.D.
        • et al.
        Sex disparities in cancer incidence by period and age.
        Cancer Epidemiol Biomarkers Prev. 2009; 18: 1174-1182
        • Derakhshan M.H.
        • Liptrot S.
        • Paul J.
        • Brown I.L.
        • Morrison D.
        • McColl K.E.
        Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females.
        Gut. 2009; 58: 16-23
        • Rutegard M.
        • Shore R.
        • Lu Y.
        • Lagergren P.
        • Lindblad M.
        Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970–2006.
        Eur J Cancer. 2010; 46: 1093-1100
        • Nordenstedt H.
        • El-Serag H.
        The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006).
        Scand J Gastroenterol. 2011; 46 (Epub 2011 Jan 28): 597-602
        • Lagergren J.
        • Jansson C.
        Sex hormones and oesophageal adenocarcinoma: influence of childbearing?.
        Br J Cancer. 2005; 93: 859-861
        • Lindblad M.
        • Garcia Rodriguez L.A.
        • Chandanos E.
        • Lagergren J.
        Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas.
        Br J Cancer. 2006; 94: 136-141
        • Lagergren J.
        • Nyren O.
        Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients.
        Cancer Epidemiol Biomarkers Prev. 1998; 7: 913-915
        • Cheng K.K.
        • Sharp L.
        • McKinney P.A.
        • et al.
        A case–control study of oesophageal adenocarcinoma in women: a preventable disease.
        Br J Cancer. 2000; 83: 127-132
        • Cronin-Fenton D.P.
        • Murray L.J.
        • et al.
        Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.
        Eur J Cancer. 2010; 46: 2067-2076
        • Andersson M.
        • Storm H.H.
        • Mouridsen H.T.
        Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer.
        J Natl Cancer Inst. 1991; 83: 1013-1017
        • Curtis R.E.
        • Boice Jr., J.D.
        • Shriner D.A.
        • Hankey B.F.
        • Fraumeni Jr., J.F.
        Second cancers after adjuvant tamoxifen therapy for breast cancer.
        J Natl Cancer Inst. 1996; 88: 832-834
        • Chandanos E.
        • Lindblad M.
        • Jia C.
        • Rubio C.A.
        • Ye W.
        • Lagergren J.
        Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
        Br J Cancer. 2006; 95: 118-122
      2. Cooper SC, Croft S, Day R, Thomson CS, Trudgill NJ. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma? Cancer Causes Control; 2009.

      3. Tihan T, Harmon JW, Wan X, et al. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 2001;21(4B):3107–14.

        • Awan A.K.
        • Iftikhar S.Y.
        • Morris T.M.
        • et al.
        Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth.
        Eur J Surg Oncol. 2007; 33: 561-568